-
Half of Voters Support Plan to Let Medicare Negotiate Drug Prices Opens in a new window)
56% of voters support allowing the federal government to negotiate some prescription drug prices in general. -
Unpopulism Opens in a new window)
Why are Democrats talking about scrapping some of the most popular parts of their agenda?Comments
-
Lilly to Cut Price of Lispro Insulin Injection by 40% From Jan. 1 Opens in a new window)
The move would bring down the price of Insulin Lispro Injection to $82.41 for individual vials and $159.12 for a pack of five pens.Comments
-
People Share Their Stories: The Human Cost of High Prescription Drug Prices Opens in a new window)
Why AARP keeps fighting to get your medication expenses under control.Comments
-
Big Business Lobbies Bitterly Divided Over Drug Pricing Reform Opens in a new window)
The biggest-spending lobbying organization in the country, the U.S. Chamber of Commerce, adamantly opposes Democrats’ ideas for drug pricing reform, saying they are unwelcome government price controls.Comments
-
An Ad’s Charge That Price Haggling Would ‘Swipe $500 Billion From Medicare’ Is Incorrect Opens in a new window)
“These guys [insurance companies and Washington bureaucrats] are working together to swipe $500 billion from Medicare to pay for Pelosi and Schumer’s out-of-control spending spree.”Comments
-
Medicare Drug-Pricing Fight Centers on California Democrat Scott Peters Opens in a new window)
Rep. Scott Peters, a California Democrat, is drawing fire from liberal lawmakers and groups in the fight to lower prescription-drug costs.Comments
-
Global Vaccines Project to Revamp Rules After Britain Got More Than Botswana Opens in a new window)
UK was among few countries that had Pfizer freezers, Gavi says.Comments
-
In May, 10 Moderate Democrats Opposed Major Drug Pricing Reform. Ahead of a Key Vote, That List is Shrinking Opens in a new window)
Ten House Democrats fired a warning shot in the spring that they could cause trouble for House Speaker Nancy Pelosi’s signature drug pricing reform legislation.Comments
-
Picture Is Worth 1,000 Meetings: ‘Snapshots’ Could Support ‘Breakthrough’ Dialogue At US FDA Opens in a new window)
US FDA’s Oncology Center of Excellence is eager to pilot test ‘Drug Development Snapshots’ as a potential tool to optimize communication for drugs receiving the Breakthrough Therapy Designation.Comments
-
Real-World Evidence Under Consideration For Use In Interchangeable Biosimilars Applications Opens in a new window)
US FDA research funded under BSUFA III will investigate what kind of safety data is needed for interchangeability.Comments
-
Free Riders and the U.S. Drug-Price Dilemma Opens in a new window)
Why should the burden of drug development costs fall overwhelmingly on the U.S. consumer?Comments
-
Inflation and Rebates Caused Wholesale Prices on Medicines to Drop in Second Quarter Opens in a new window)
Meanwhile, after subtracting allowances such as rebates and discounts, net prices that health plans paid for medicines dropped by 1.4%, compared with a 1.8% decline in last year’s second quarter, according to SSR Health.Comments
-
Small Biotechs May Be Spared in Drug Bill Opens in a new window)
A Senate leader crafting a drug pricing proposal is trying to win the support of moderate Democrats by promising to carve out exceptions for small biotech companies.Comments
-
The Road to Aduhelm Opens in a new window)
What one ex-FDA adviser called 'probably the worst drug approval decision in recent US history' for an Alzheimer's treatment.Comments
Comments